Abstract
EPS8.03 Impact of 12 months of elexacaftor/tezacaftor/ivacaftor on pulmonary function and exercise capacity in patients with cystic fibrosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have